Anti-Podoplanin antibody [18H5] - BSA and Azide free

7 product images

• 

  Flow Cytometry - Anti-Podoplanin antibody [18H5] - BSA and Azide free (ab10288)

  Overlay histogram showing HCT116 cells stained with ab10288 (red line). The cells were fixed with methanol (5 min) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab10288, 1µg/1x10⁶ cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (Goat Anti-Mouse IgG H&L (DyLight® 488) preadsorbed ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (Mouse IgG1, Kappa Monoclonal [B11/6] - Isotype Control ab91353, 2µg/1x10⁶ cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a slightly decreased signal in HCT116 cells fixed with 4% paraformaldehyde (10 min) used under the same conditions.
  
  Please note that Abcam does not have data for use of this antibody on non-fixed cells. We welcome any customer feedback.
  

• 

  Flow Cytometry - Anti-Podoplanin antibody [18H5] - BSA and Azide free (ab10288)

  Flow cytometric analysis of human primary lymphatic endothelial cells (HDLEC) labeling Podoplanin with ab10288 at 5 μg/mL. Anti-mouse IgG-PE was used as a secondary antibody.
  

• 

  Flow Cytometry - Anti-Podoplanin antibody [18H5] - BSA and Azide free (ab10288)

  Flow cytometric analysis of primary human dermal microvascular (HDMVEC) and umbilical vein (HUVEC) endothelial cells labeling Podoplanin with ab10288 at 5 μg/mL. The lymphatic endothelial cell marker Podoplanin is not expressed in the blood endothelial cells.

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Podoplanin antibody [18H5] - BSA and Azide free (ab10288)

  ab10288 at a 1/500 dilution staining human dermal lymphatic endothelial by Immunocytochemistry. The cells were grown in coverslips and fixed in formalin prior to permeabilization with tritonX-100. The cells were incubated with the primary antibody at 1/500 for 1 hour and then bound antibody was detected using a biotinylated goat anti-mouse antibody. Texas red-streptavidin was used for development.

  This image is courtesy of an Abreview submitted by Maria Navarro.

• 

  Western blot - Anti-Podoplanin antibody [18H5] - BSA and Azide free (ab10288)

  Podoplanin protein is extensively glycosylated. This might explain the observation of a band at a higher molecular weight than predicted.

  All lanes: Western blot - Anti-Podoplanin antibody [18H5] - BSA and Azide free (ab10288) at 5 µg/mL

  Lane 1: Human placenta tissue lysate - total protein (ab29745) at 20 µg

  Lane 2: Human skeletal muscle tissue lysate - total protein (ab29330) at 20 µg

  Secondary

  All lanes: Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (Goat Anti-Mouse IgG H&L (HRP) preadsorbed ab97040) at 1/5000 dilution

  Developed using the ECL technique.

  Performed under reducing conditions.

  Predicted band size: 16 kDa

  Observed band size: 35 kDa

  Exposure time: 20min

• 

  Western blot - Anti-Podoplanin antibody [18H5] - BSA and Azide free (ab10288)

  Western blot analysis of Podoplanin expression in human lymphatic endothelial cells (LEC) - lane 1, and HUVECs - lane 2. Total lysate of both cell types were subjected to SDS-PAGE and subsequent western blot analysis with ab10288. The antibody recognizes a protein of about 36 kDa in total lysate from LECs but not from HUVEC.

  All lanes: Western blot - Anti-Podoplanin antibody [18H5] - BSA and Azide free (ab10288)

  Predicted band size: 16 kDa

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Podoplanin antibody [18H5] - BSA and Azide free (ab10288)

  Immunocytochemistry/Immunofluorescence analysis of human dermal lymphatic endothelial cells (HDLEC) labelling Podoplanin with ab10288. An Alexa Fluor^® 488-conjugated goat anti-mouse was used as the secondary antibody. Nuclei counterstained with DAPI.